In the News
CHCWM clinical trial published in esteemed lung cancer journal
01/22/2020
Cancer & Hematology Centers of Western Michigan (CHCWM)’s ongoing ADRIATIC clinical trial study design and eligibility was recently published in leading academic journal, Clinical Lung Cancer. ADRIATIC is the first international phase III trial studying the benefit of immunotherapy as consolidation »
CHCWM oncologist Sreenivasa Chandana, M.D., Ph.D., publishes article in ‘Journal of Gastrointestinal Oncology’
10/28/2019
Cancer and Hematology Centers of Western Michigan (CHCWM) oncologist Sreenivasa Chandana, M.D., Ph.D., is one of six authors of “Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database,” which was published in Journal of Gastrointestinal Read more »
RCWM featured on Wood TV8’s eightWest
10/18/2019
Rheumatology Centers of Western Michigan (RCWM)’s Dr. Philip Velderman and Dr. Lakshmi Kocharla were featured on Wood TV8’s eightWest show on Oct. 18, 2019. To see our two physicians talk about Cancer and Hematology Centers of Western Michigan (CHCWM)’s newest Read more »
CHCWM clinical trial published in esteemed medical journal
10/09/2019
One of the oldest, most prestigious medical journals, The Lancet, recently published AstraZeneca’s Phase III CASPIAN trial, of which Cancer and Hematology Centers of Western Michigan (CHCWM) was a leading site. CASPIAN showed that Imfinzi (an anti-PDL1 immunotherapy from AstraZeneca), in combination Read more »
CHCWM’s Yuanbin Chen, M.D., Ph.D. author of working group guideline detailing liquid biopsy for lung cancer
10/04/2019
Cancer and Hematology Centers of Western Michigan (CHCWM) oncologist Dr. Yuanbin Chen, M.D., Ph.D. is one of six authors of “Incorporating Liquid Biopsy into Routine Practice for Patients with aNSCLC: A Practical Guideline for Community Oncologists from the Liquid Biopsy Read more »
CHCWM/START Midwest participate in three clinical trials presented at 2019 World Conference on Lung Cancer
09/16/2019
Cancer & Hematology Centers of Western Michigan (CHCWM) and START Midwest were involved in three groundbreaking clinical trials that were presented at the International Association for the Study of Lung Cancer (IASLC)’s 2019 World Conference on Lung Cancer (WCLC) in Read more »